Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article
Evaluation of Stearylamine-Modified Liposomes for the Oral Vaccine Adjuvant
| Division of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Japan | ||
| Corresponding Author : | Watarai S Division of Veterinary Science Graduate School of Life and Environmental Sciences Osaka Prefecture University, 1-58 Rinkuohraikita Izumisano, Osaka 598-8531, Japan Tel: +81-72-463-5720 Fax: +81-72-463-5720 E-mail: swatarai@vet.osakafu-u.ac.jp |
|
| Received March 25, 2014; Accepted April 27, 2014; Published May 02, 2014 | ||
| Citation: Watarai S and Sasaki Y (2014) Evaluation of Stearylamine-Modified Liposomes for the Oral Vaccine Adjuvant. J Infect Dis Ther 2:141. doi:10.4172/2332-0877.1000141 | ||
| Copyright: © 2014 Watarai S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | ||
Related article at Pubmed Scholar Google |
||
Abstract
The usefulness of stearylamine (SA)-modified liposomes for the oral vaccine adjuvant in the induction of immune responses was evaluated. Mice were orally immunized withunmodified liposomes containing ovalbumin (OVA) (group I), OVA-containing monophosphoryl lipid A (MPL)-modified liposomes (group II), OVA-having SA-modified liposomes (group III) or OVA alone (group IV). After immunization, significant OVA-specific antibodies were detected in the serum and intestine from mice of groups I to III, but not in group IV. Especially, intestinal IgG and IgA antibody responses against OVA were significantly higher in mice of group III than in groups I and II. When sera were analyzed for isotype distribution,OVA-specific IgG1 antibody responses were noted in mice of groups I and II, whereas the induction of OVA-specific IgG1 and IgG3 antibody responses was observed in mice of group III. Moreover, substantial production of IFN-γ(Th1-type) and IL-4 (Th2 type) was demonstrated in spleen cells from mice of group III in vitro. These results suggest that the SA-modified liposomes would serve effectively as mucosal vaccine adjuvant for inducing humoral and cell-mediated immune responses.
